The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients
Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects
RI-MUHC veterinarians engage in global effort to understand SARS-Cov-2
ARD platform members take centre stage at the 2020 Quebec Veterinary Congress
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
Canada approves HIV self-testing kit ahead of World AIDS Day 2020
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
RI-MUHC team identifies new gene associated with risk of cardiovascular diseases
New study analyses millions of genetic variants in almost 300,000 individuals
New services for cancer patients at the RI-MUHC Centre for Innovative Medicine
The Centre for Innovative Medicine and Cedars Cancer Centre jointly offer additional space for infusion treatments
What do we know about sleep apnea, pregnancy and gestational diabetes?
RI-MUHC researchers find link that may lead to better health for mother and baby
Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2
Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds
A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...
Recovering from sleep deprivation: What is the role of astrocytes?
A new RI-MUHC study uses sleep-deprived fruit flies to study regulation of rebound sleep